Last update 10 May 2025

MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital)

Overview

Basic Info

Drug Type
TCR-T Cell therapy
Synonyms-
Target
MAGEA4
Action
modulators
Mechanism
MAGEA4 modulators(Melanoma-associated antigen 4 modulators)
Therapeutic Areas
NeoplasmsRespiratory DiseasesSkin and Musculoskeletal Diseases
Active Indication-
Inactive Indication
Lung CancerMalignant Solid NeoplasmMelanoma
Originator Organization
Tianjin Cancer Institute
Active Organization-
Inactive Organization
Tianjin Cancer Institute
License Organization-
Drug Highest PhasePendingPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital)
NCT01694472
/ Unknown statusPhase 1IIT
Phase 1 Study of MAGE-A4 TCR Gene-Modified T Cells to Treat Malignant Tumors
100 Clinical Results associated with MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital)
Login to view more data
100 Translational Medicine associated with MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital)
Login to view more data
100 Patents (Medical) associated with MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital)
Login to view more data
100 Deals associated with MAGE-A4 TCR Gene-Modified T Cells(Tianjin Medical University Cancer Institute and Hospital)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Lung CancerPhase 1
China
Tianjin Cancer Institute
01 Jul 2012
Malignant Solid NeoplasmPhase 1
China
Tianjin Cancer Institute
01 Jul 2012
MelanomaPhase 1
China
Tianjin Cancer Institute
01 Jul 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free